Cargando…
The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents
SARS-CoV-2 infection (COVID-19) results in local and systemic activation of inflammation and coagulation. In this review article, we will discuss the potential role of coagulation factor Xa (FXa) in the pathophysiology of COVID-19. FXa, a serine protease, has been shown to play a role in the cleavag...
Autores principales: | Frydman, Galit H., Streiff, Michael B., Connors, Jean M., Piazza, Gregory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541169/ https://www.ncbi.nlm.nih.gov/pubmed/33043235 http://dx.doi.org/10.1055/s-0040-1718415 |
Ejemplares similares
-
Roles of factor Xa beyond coagulation
por: Ruf, Wolfram
Publicado: (2021) -
Coagulation Factor Xa
por: Brown, Mark A., et al.
Publicado: (2013) -
Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19
por: Frydman, Galit H., et al.
Publicado: (2020) -
Rivaroxaban‐calibrated chromogenic anti‐Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation
por: Lucas, Fabienne, et al.
Publicado: (2021) -
Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections
por: Al-Horani, Rami A.
Publicado: (2020)